FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Stent, Superficial Femoral Artery, Drug-Eluting
PMA: P180011
·
Supplement: S060
·
Decision Jan 30, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0
Research PMA P180011 in seconds
The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Stent, Superficial Femoral Artery, Drug-Eluting
- Trade Name
- Eluvia Drug-Eluting Vascular Stent System
- PMA Number
- P180011
- Supplement Number
- S060
- Device Class
- FDA Class 3
- Product Code
- NIU
- Generic Name
- Stent, superficial femoral artery, drug-eluting
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- January 30, 2026
- Date Received
- June 20, 2024
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Labeling Change - PAS
- Expedited Review
- N
Advisory Committee Statement
Approval for the post-approval labeling update to reflect the findings of the EMINENT post-approval study.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NIU | Stent, Superficial Femoral Artery, Drug-Eluting | FDA class 3 | Unknown |